Wed like to find a path to yes there on coverage over time, but there are some notable challenges and outstanding questions with the currently planned structure, Bobby Hunter, UnitedHealthcares CEO of government programs, said during Tuesdays earnings call about the pilot program
Treating whilst weight is still fluctuating may require additional adjustments and could result in less satisfactory outcomes as facial volume continues to change
Who Qualifies for a GLP-1 Prescription
A temporary drop in potassium This is the most clinically recognised reason to feel worse early in treatment
Weight loss on these medications is fast, and that speed carries a hidden cost: clinical trial data shows that without resistance training, a third or more of the weight lost can be muscle rather than fat
Declining undernutrition in India & other LMICs reduces MRDMs current relevance